Drug shortages in developed countries-reasons, therapeutic consequences, and handling

被引：50

作者：

Dill, Susie ^{[1
]}

Ahn, Jin ^{[1
]}

机构：

[1] US FDA, Silver Spring, MD 20993 USA

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2014年 / 70卷 / 12期

关键词：

Sterile injectables; Manufacturers; Drug shortages;

D O I：

10.1007/s00228-014-1747-1

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Drug shortages in developed countries pose a serious public health problem and have far-reaching implications for healthcare providers and their patients. Given the current state of the market, with the limited number of manufacturers and the array of manufacturing quality issues, drug shortages have become a global concern, forcing regulatory authorities to explore and implement strategies to prevent and mitigate drug shortages.

引用

页码：1405 / 1412

页数：8

共 9 条

[1]

[Anonymous], 2014, DRUG SHORTAGES 2014

[2]

[Anonymous], 2011, EMA7188272011

[3]

[Anonymous], 2011, EMA7188272011

[4]

[Anonymous], 2013, MULTISTAKEHOLDER STE

[5]

European Association of Hospital Pharmacists (AEHP), MED SHORT

[6]

European Medicines Agency, 2013, AG EUR UN SHORT MED

[7]

European Medicines Agency, 2012, REFL PAP MED PROD SU

[8] National survey on the effect of oncology drug shortages on cancer care [J].

McBride, Ali ;

Holle, Lisa M. ;

Westendorf, Colleen ;

Sidebottom, Margaret ;

Griffith, Niesha ;

Muller, Raymond J. ;

Hoffman, James M. .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (07) :609-617

[9]

U.S. Food and Drug Administration, 2012, MAN POL PROC

← 1 →